System level dynamics of post-translational modifications

Current Opinion in Biotechnology

Volumn 28, Issue , 2014, Pages 83-87

  Gajadhar, Aaron S ^a,b   White, Forest M ^a,b,c  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL COMPLEXITY; COMPUTATIONAL MODEL; ENHANCED RESOLUTIONS; HIGH RESOLUTION MASS SPECTROMETRY; MULTIPLEX MEASUREMENT; POST-TRANSLATIONAL MODIFICATIONS; REGULATORY NETWORK; SIGNALING PATHWAYS;

MASS SPECTROMETRY;

COMPLEX NETWORKS;

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

DNA DAMAGE; DNA REPAIR; ENDOTHELIUM CELL; ENZYME SUBSTRATE; HUMAN; INTRACELLULAR SIGNALING; MASS SPECTROMETRY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; UBIQUITINATION;

ANIMALS; HUMANS; MASS SPECTROMETRY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; SIGNAL TRANSDUCTION;

EID: 84892456405     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.12.009     Document Type: Review

References (48)

1. Ivanov A.A., Khuri F.R., Fu H. Targeting protein-protein interactions as an anticancer strategy. Trends Pharmacol Sci 2013, 34:393-400.
2. Rivera C.M., Ren B. Mapping human epigenomes. Cell 2013, 155:39-55.
3. Federica Calore F.L.M.G. Non-coding RNAs and cancer. Int J Mol Sci 2013, 14:17085.
4. Seet B.T., Dikic I., Zhou M.-M., Pawson T. Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 2006, 7:473-483.
5. Deribe Y.L., Pawson T., Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol 2010, 17:666-672.
6. Krüger R., Kübler D., Pallissé R., Burkovski A., Lehmann W.D. Protein and proteome phosphorylation stoichiometry analysis by element mass spectrometry. Anal Chem 2006, 78:1987-1994.
7. Derouiche A., Cousin C., Mijakovic I. Protein phosphorylation from the perspective of systems biology. Curr Opin Biotechnol 2012, 23:585-590.
8. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995, 80:225-236.
9. Huang P.H., Miraldi E.R., Xu A.M., Kundukulam V.A., del Rosario A.M., Flynn R.A., Cavenee W.K., Furnari F.B., White F.M. Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Biosyst 2010, 6:1227-1237.
10. Huang P.H., Mukasa A., Bonavia R., Flynn R.A., Brewer Z.E., Cavenee W.K., Furnari F.B., White F.M. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci USA 2007, 104:12867-12872.
11. Schwanbeck R., Martini S., Bernoth K., Just U. The Notch signaling pathway: molecular basis of cell context dependency. Eur J Cell Biol 2011, 90:572-581.
12. Fey D., Croucher D.R., Kolch W., Kholodenko B.N. Crosstalk and signaling switches in mitogen-activated protein kinase cascades. Front Physiol 2012, 3:355.
13. Janes K.A., Albeck J.G., Gaudet S., Sorger P.K., Lauffenburger D.A., Yaffe M.B. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005, 310:1646-1653.
14. Altelaar A.F.M., Munoz J., Heck A.J.R. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet 2013, 14:35-48.
15. del Rosario A.M., White F.M. Quantifying oncogenic phosphotyrosine signaling networks through systems biology. Curr Opin Genet Dev 2010, 20:23-30.
16. Bensimon A., Heck A.J.R., Aebersold R. Mass spectrometry-based proteomics and network biology. Annu Rev Biochem 2012, 81:379-405.
17. Ideker T., Krogan N.J. Differential network biology. Mol Syst Biol 2012, 8:565.
18. Wolf-Yadlin A., Kumar N., Zhang Y., Hautaniemi S., Zaman M., Kim H.-D., Grantcharova V., Lauffenburger D.A., White F.M. Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Syst Biol 2006, 2:54.
19. Cohen P. The regulation of protein function by multisite phosphorylation-a 25 year update. Trends Biochem Sci 2000, 25:596-601.
20. Stasyk T., Huber L.A. Mapping in vivo signal transduction defects by phosphoproteomics. Trends Mol Med 2012, 18:43-51.
21. Zhuang G., Yu K., Jiang Z., Chung A., Yao J., Ha C., Toy K., Soriano R., Haley B., Blackwood E., et al. Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases. Sci Signal 2013, 6:ra25.
22. Halim V.A., Alvarez-Fernández M., Xu Y.J., Aprelia M., van den Toorn H.W.P., Heck A.J.R., Mohammed S., Medema R.H. Comparative phosphoproteomic analysis of checkpoint recovery identifies new regulators of the DNA damage response. Sci Signal 2013, 6:rs9.
23. Carlson S.M., Chouinard C.R., Labadorf A., Lam C.J., Schmelzle K., Fraenkel E., White F.M. Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. Sci Signal 2011, 4:rs11.
24. Berchowitz L.E., Gajadhar A.S., van Werven F.J., De Rosa A.A., Samoylova M.L., Brar G.A., Xu Y., Xiao C., Futcher B., Weissman J.S., et al. A developmentally regulated translational control pathway establishes the meiotic chromosome segregation pattern. Genes Dev 2013, 27:2147-2163.
25. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
26. Wang Q., Zhang Y., Yang C., Xiong H., Lin Y., Yao J., Li H., Xie L., Zhao W., Yao Y., et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010, 327:1004-1007.
27. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
28. Martin B.R., Wang C., Adibekian A., Tully S.E., Cravatt B.F. Global profiling of dynamic protein palmitoylation. Nat Methods 2012, 9:84-89.
29. Xu G., Paige J.S., Jaffrey S.R. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat Biotechnol 2010, 28:868-873.
30. Povlsen L.K., Beli P., Wagner S.A., Poulsen S.L., Sylvestersen K.B., Poulsen J.W., Nielsen M.L., Bekker-Jensen S., Mailand N., Choudhary C. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol 2012, 14:1089-1098.
31. Bremang M., Cuomo A., Agresta A.M., Stugiewicz M., Spadotto V., Bonaldi T. Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. Mol Biosyst 2013, 9:2231-2247.
32. Wang G.G., Allis C.D., Chi P. Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med 2007, 13:363-372.
33. Swaney D.L., Beltrao P., Starita L., Guo A., Rush J., Fields S., Krogan N.J., Villén J. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Nat Methods 2013, 10:676-682.
34. Woodsmith J., Kamburov A., Stelzl U. Dual coordination of post translational modifications in human protein networks. PLoS Comput Biol 2013, 9:e1002933.
35. Beltrao P., Albanèse V., Kenner L.R., Swaney D.L., Burlingame A., Villén J., Lim W.A., Fraser J.S., Frydman J., Krogan N.J. Systematic functional prioritization of protein posttranslational modifications. Cell 2012, 150:413-425.
36. Hebert A.S., Merrill A.E., Stefely J.A., Bailey D.J., Wenger C.D., Westphall M.S., Pagliarini D.J., Coon J.J. Amine-reactive neutron-encoded labels for highly-plexed proteomic quantitation. Mol Cell Proteom 2013, 10.1074/mcp.M113.032011.
37. Hebert A.S., Merrill A.E., Bailey D.J., Still A.J., Westphall M.S., Strieter E.R., Pagliarini D.J., Coon J.J. Neutron-encoded mass signatures for multiplexed proteome quantification. Nat Methods 2013, 10:332-334.
38. Wu R., Haas W., Dephoure N., Huttlin E.L., Zhai B., Sowa M.E., Gygi S.P. A large-scale method to measure absolute protein phosphorylation stoichiometries. Nat Methods 2011, 8:677-683.
39. Salek M., Acuto O. Quantitative dynamics of phosphoproteome: the devil is in the details. Anal Chem 2012, 84:8431-8436.
40. White F.M. The potential cost of high-throughput proteomics. Sci Signal 2011, 4:pe8.
41. Curran T.G., Bryson B.D., Reigelhaupt M., Johnson H., White F.M. Computer aided manual validation of mass spectrometry-based proteomic data. Methods 2013, 10.1016/j.ymeth.2013.03.004.
42. Naegle K.M., Welsch R.E., Yaffe M.B., White F.M., Lauffenburger D.A. MCAM: multiple clustering analysis methodology for deriving hypotheses and insights from high-throughput proteomic datasets. PLoS Comput Biol 2011, 7:e1002119.
43. Naegle K.M., White F.M., Lauffenburger D.A., Yaffe M.B. Robust co-regulation of tyrosine phosphorylation sites on proteins reveals novel protein interactions. Mol Biosyst 2012, 8:2771-2782.
44. Huang S-SC, Fraenkel E. Integrating proteomic, transcriptional, and interactome data reveals hidden components of signaling and regulatory networks. Sci Signal 2009, 2:ra40.
45. Linding R., Jensen L.J., Ostheimer G.J., van Vugt M.A.T.M., Jørgensen C., Miron I.M., Diella F., Colwill K., Taylor L., Elder K., et al. Systematic discovery of in vivo phosphorylation networks. Cell 2007, 129:1415-1426.
46. Pawson T., Linding R. Network medicine. FEBS Lett 2008, 582:1266-1270.
47. Behar M., Barken D., Werner S.L., Hoffmann A. The dynamics of signaling as a pharmacological target. Cell 2013, 155:448-461.
48. Lee M.J., Ye A.S., Gardino A.K., Heijink A.M., Sorger P.K., MacBeath G., Yaffe M.B. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012, 149:780-794.